舞台已经为$诺和诺德_老虎社区_美港股上老虎

舞台已经为$诺和诺德(NVO)$ 重新夺回领先地位扫清障碍。$礼来(LLY)$ 和$Viking Therapeutics, Inc.(VKTX)$ 的二期药物试验结果让市场大失所望，反观$诺和诺德(NVO)$ 不仅斩获FDA批准的肝脏疾病新药，后续产品线更是兵强马壮。年底剑指80刀指日可待。

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":469641850540056,"tweetId":"469641850540056","gmtCreate":1755659180000,"gmtModify":1755745880718,"author":{"id":9000000000000150,"idStr":"9000000000000150","authorId":9000000000000150,"authorIdStr":"9000000000000150","name":"0孙悟空0","avatar":"https://static.tigerbbs.com/125de50306f11281ed8b506e80cb5976","vip":8,"userType":8,"introduction":"运营账号","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":16,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><p>舞台已经为<a href=\"https://laohu8.com/S/NVO\">$诺和诺德(NVO)$&nbsp;</a>重新夺回领先地位扫清障碍。<a href=\"https://laohu8.com/S/LLY\">$礼来(LLY)$&nbsp;</a>和<a href=\"https://laohu8.com/S/VKTX\">$Viking Therapeutics, Inc.(VKTX)$&nbsp;</a>的二期药物试验结果让市场大失所望，反观<a href=\"https://laohu8.com/S/NVO\">$诺和诺德(NVO)$&nbsp;</a>不仅斩获FDA批准的肝脏疾病新药，后续产品线更是兵强马壮。年底剑指80刀指日可待。</p></body></html>","htmlText":"<html><head></head><body><p>舞台已经为<a href=\"https://laohu8.com/S/NVO\">$诺和诺德(NVO)$&nbsp;</a>重新夺回领先地位扫清障碍。<a href=\"https://laohu8.com/S/LLY\">$礼来(LLY)$&nbsp;</a>和<a href=\"https://laohu8.com/S/VKTX\">$Viking Therapeutics, Inc.(VKTX)$&nbsp;</a>的二期药物试验结果让市场大失所望，反观<a href=\"https://laohu8.com/S/NVO\">$诺和诺德(NVO)$&nbsp;</a>不仅斩获FDA批准的肝脏疾病新药，后续产品线更是兵强马壮。年底剑指80刀指日可待。</p></body></html>","text":"舞台已经为$诺和诺德(NVO)$ 重新夺回领先地位扫清障碍。$礼来(LLY)$ 和$Viking Therapeutics, Inc.(VKTX)$ 的二期药物试验结果让市场大失所望，反观$诺和诺德(NVO)$ 不仅斩获FDA批准的肝脏疾病新药，后续产品线更是兵强马壮。年底剑指80刀指日可待。","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/469641850540056","repostId":0,"isVote":1,"tweetType":1,"viewCount":757,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["VKTX","LLY","NVO"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":220,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/469641850540056"}